Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the findings of a study that documents the actions clinicians take...

Related Keywords

Swaroop Aradhya ,Dee Mcknight ,Renee Kelley ,Exchange Commission ,Invitae Corporation ,National Society Of Genetic Counselors ,Genetic Counselors ,Private Securities Litigation Reform Act ,Quarterly Report ,